Recent Finacing
Recent Raise
Abeona Therapeutics develops CRISPR/Cas9 and gene‑replacement therapies for rare genetic disorders, including MPS IIIA/IIIB (Sanfilippo), Fanconi anemia, and juvenile Batten, using Cas9 RNPs and gene delivery.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
